Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus

(2014) Hilary A Robbins et al.   BMC INFECTIOUS DISEASES

Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study

(2013) Lauren E. Wilson et al.   INTERNATIONAL JOURNAL OF CANCER

Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women

(2012) Jia Ji et al.   BMC INFECTIOUS DISEASES

Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile

(2012) Catterina Ferreccio et al.   INTERNATIONAL JOURNAL OF CANCER

Age-Specific Seroprevalence of Human Papillomavirus 16, 18, 31, and 58 in Women of a Rural Town of Colombia

(2012) Astrid M. Bedoya et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Seroprevalence of seven high-risk HPV types in The Netherlands

(2012) Mirte Scherpenisse et al.   VACCINE

High-risk HPV infection after five years in a population-based cohort of Chilean women

(2012) Catterina Ferreccio et al.   Infectious Agents and Cancer

Worldwide burden of cervical cancer in 2008

(2011) M. Arbyn et al.   ANNALS OF ONCOLOGY

Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women

(2011) Jennifer S. Smith et al.   INTERNATIONAL JOURNAL OF CANCER

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

(2011) Mohammad H Forouzanfar et al.   LANCET

Prevalence of Human Papillomavirus Antibodies in Males and Females in England

(2011) Sarika Desai et al.   SEXUALLY TRANSMITTED DISEASES

HPV genotyping from invasive cervical cancer in Chile

(2009) Juan Carlos Roa et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia

(2009) T. Waterboer et al.   JOURNAL OF GENERAL VIROLOGY

Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy

(2009) S. Syrjanen et al.   JOURNAL OF GENERAL VIROLOGY

Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004

(2009) Lauri E. Markowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Persistent Antibodies to HPV Virus-Like Particles Following Natural Infection Are Protective Against Subsequent Cervicovaginal Infection with Related and Unrelated HPV

(2009) Zainab A. Malik et al.   VIRAL IMMUNOLOGY

Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples

(2008) Catterina Ferreccio et al.   BMC PUBLIC HEALTH

Human Papillomavirus Infection in Ulaanbaatar, Mongolia: A Population-Based Study

(2008) B. Dondog et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Measurement of the Humoral Immune Response following an Incident Human Papillomavirus Type 16 or 18 Infection in Young Women by a Pseudovirion-Based Neutralizing Antibody Assay

(2008) J. Steele et al.   Clinical and Vaccine Immunology

Population Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia

(2008) Anthony T. Newall et al.   CLINICAL INFECTIOUS DISEASES